Journal article
Complement biomarkers as predictors of disease progression in Alzheimer's disease.
- Abstract:
-
There is a critical unmet need for reliable markers of disease and disease course in mild cognitive impairment (MCI) and early Alzheimer's disease (AD). The growing appreciation of the importance of inflammation in early AD has focused attention on inflammatory biomarkers in cerebrospinal fluid or plasma; however, non-specific inflammation markers have disappointed to date. We have adopted a targeted approach, centered on an inflammatory pathway already implicated in the disease. Complement, ...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
Kings College London
More from this funder
National Institute for Health Research
More from this funder
London and Maudsley NHS Foundation Trust
More from this funder
Sixth Framework Programme
More from this funder
Alzheimer's Research UK
More from this funder
Bibliographic Details
- Publisher:
- IOS Press Publisher's website
- Journal:
- Journal of Alzheimer's Disease Journal website
- Volume:
- 54
- Issue:
- 2
- Pages:
- 707-716
- Publication date:
- 2016-09-01
- Acceptance date:
- 2016-06-14
- DOI:
- EISSN:
-
1875-8908
- ISSN:
-
1387-2877
- Pmid:
-
27567854
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:641618
- UUID:
-
uuid:a6a19553-7d7f-4a25-b959-aabf599538da
- Local pid:
- pubs:641618
- Source identifiers:
-
641618
- Deposit date:
- 2017-07-18
Terms of use
- Copyright holder:
- IOS Press and the authors
- Copyright date:
- 2016
- Notes:
- © 2016 – IOS Press and the authors. All rights reserved
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record